*Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA; †Bridge HIV, San Francisco Department of Public Health, San Francisco, CA; ‡Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA; §Department of Medicine, University of California, San Francisco, San Francisco, CA; and ‖PaxVax, San Diego, CA.
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):115-21. doi: 10.1097/QAI.0b013e3182a98bae.
Young men who have sex with men (MSM) and MSM of color have the highest HIV incidence in the United States. To explore possible explanations for these disparities and known individual risk factors, we analyzed the per contact risk (PCR) of HIV seroconversion in the early highly active antiretroviral therapy era.
Data from 3 longitudinal studies of MSM (HIV Network for Prevention Trials Vaccine Preparedness Study, EXPLORE behavioral efficacy trial, and VAX004 vaccine efficacy trial) were pooled. The analysis included visits where participants reported unprotected receptive anal intercourse (URA), protected receptive anal intercourse, or unprotected insertive anal intercourse (UIA) with an HIV seropositive, unknown HIV serostatus, or an HIV seronegative partner. We used regression standardization to estimate average PCRs for each type of contact, with bootstrap confidence intervals.
The estimated PCR was highest for URA with an HIV seropositive partner (0.73%; 95% bootstrap confidence interval [BCI]: 0.45% to 0.98%) followed by URA with a partner of unknown HIV serostatus (0.49%; 95% BCI: 0.32% to 0.62%). The estimated PCR for protected receptive anal intercourse and UIA with an HIV seropositive partner was 0.08% (95% BCI: 0.0% to 0.19%) and 0.22% (95% BCI: 0.05% to 0.39%), respectively. Average PCRs for URA and UIA with HIV seropositive partners were higher by 0.14%-0.34% among younger participants and higher by 0.08% for UIA among Latino participants compared with white participants. Estimated PCRs increased with the increasing number of sexual partners, use of methamphetamines or poppers, and history of sexually transmitted infection.
Susceptibility or partner factors may explain the higher HIV conversion risk for younger MSM, some MSM of color, and those reporting individual risk factors.
在美国,男男性行为者(MSM)和有色人种的 MSM 艾滋病毒感染率最高。为了探究这些差异和已知个体风险因素的可能解释,我们分析了早期高效抗逆转录病毒治疗时代艾滋病毒血清转换的每接触风险(PCR)。
对来自 MSM 的 3 项纵向研究的数据(HIV 网络预防试验疫苗准备研究、EXPLORE 行为功效试验和 VAX004 疫苗功效试验)进行了汇总。分析包括参与者报告无保护的接受性肛交(URA)、有保护的接受性肛交或无保护的插入性肛交(UIA)与艾滋病毒血清阳性、未知艾滋病毒血清状态或艾滋病毒血清阴性伴侣的情况。我们使用回归标准化来估计每种接触类型的平均 PCR,置信区间采用自举法。
与艾滋病毒血清阳性伴侣发生 URA 的估计 PCR 最高(0.73%;95%自举置信区间[BCI]:0.45%至 0.98%),其次是与 HIV 血清未知状态伴侣发生 URA(0.49%;95%BCI:0.32%至 0.62%)。与艾滋病毒血清阳性伴侣发生保护的接受性肛交和 UIA 的估计 PCR 分别为 0.08%(95%BCI:0.0%至 0.19%)和 0.22%(95%BCI:0.05%至 0.39%)。与艾滋病毒血清阳性伴侣发生 URA 和 UIA 的平均 PCR 分别在年轻参与者中高出 0.14%至 0.34%,在拉丁裔参与者中比白人参与者高出 0.08%。估计的 PCR 随着性伴侣数量的增加、使用冰毒或催情剂以及性传播感染史而增加。
易感性或伴侣因素可能解释了年轻 MSM、某些有色人种 MSM 和报告个体风险因素的 MSM 艾滋病毒转换风险较高的原因。